AUROBAC Trademark

Trademark Overview


On Thursday, June 15, 2023, a trademark application was filed for AUROBAC with the United States Patent and Trademark Office. The USPTO has given the AUROBAC trademark a serial number of 79375815. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 23, 2024. This trademark is owned by AUROBAC THERAPEUTICS SAS. The AUROBAC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary products, namely pharmaceutical and veterinary preparations for prevention and treatment of infectious diseases and critical care conditions, namely, systemic inflammatory response syndrome (SIRS), sepsis, and septic shock, as well as related diseases and co-morbidities; dietetic food and dietetic substances being preparations for medical or veterinary use

Scientific and technological services, namely, pharmaceutical drug development services as well as research and design services relating thereto; industrial analysis and research services, namely, research and development of new products for third parties; medical research services; research services in the fields of biology, bacteriology, and chemistry; clinical research in the field of infectious diseases and critical care; Scientific research in the nature of conducting clinical trials for others; development of pharmaceutical products
aurobac

General Information


Serial Number79375815
Word MarkAUROBAC
Filing DateThursday, June 15, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical and veterinary products, namely pharmaceutical and veterinary preparations for prevention and treatment of infectious diseases and critical care conditions, namely, systemic inflammatory response syndrome (SIRS), sepsis, and septic shock, as well as related diseases and co-morbidities; dietetic food and dietetic substances being preparations for medical or veterinary use
Goods and ServicesScientific and technological services, namely, pharmaceutical drug development services as well as research and design services relating thereto; industrial analysis and research services, namely, research and development of new products for third parties; medical research services; research services in the fields of biology, bacteriology, and chemistry; clinical research in the field of infectious diseases and critical care; Scientific research in the nature of conducting clinical trials for others; development of pharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAUROBAC THERAPEUTICS SAS
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameAUROBAC THERAPEUTICS SAS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Monday, August 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 11, 2024NON-FINAL ACTION WRITTEN
Friday, March 29, 2024REFUSAL PROCESSED BY MPU
Saturday, March 30, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 23, 2024REFUSAL PROCESSED BY IB
Friday, June 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 4, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 11, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, March 5, 2024ASSIGNED TO EXAMINER
Tuesday, March 12, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 14, 2024EXAMINERS AMENDMENT E-MAILED
Friday, June 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 14, 2024EXAMINER'S AMENDMENT ENTERED
Friday, June 14, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED